Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced intensity allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Pollack, S.
Steinberg, S.
Odom, J.
Dean, R.
Fowler, D.
Bishop, M. R.
机构：
[1] George Washington Univ, Washington, DC USA
[2] NCI, Bethesda, MD 20892 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7096
引用
收藏
页数：1
相关论文
共 50 条
  • [21] OUTCOME OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NON-HODGKIN LYMPHOMA
    Xu, T.
    Chen, J.
    Jin, Z.
    Miao, M.
    Fu, C.
    Qiu, H.
    Tang, X.
    Han, Y.
    Sun, A.
    Wu, D.
    HAEMATOLOGICA, 2016, 101 : 853 - 853
  • [22] The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma
    Laport, GG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 59 - 65
  • [23] Acceptable outcomes for patients receiving allogeneic hematopoietic stem cell transplantation (AlloSCT) for relapsed aggressive non-Hodgkin's lymphoma (NHL).
    Doocey, RT
    Song, KW
    Toze, CL
    Connors, JM
    Nevill, TJ
    Gascoyne, RD
    Barnett, MJ
    Forrest, DL
    Hogge, DE
    Lavoie, JC
    Nantel, SH
    Shepherd, JD
    Sutherland, HJ
    Voss, N
    Smith, CA
    BLOOD, 2004, 104 (11) : 908A - 908A
  • [24] Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review
    Laport, Ginna G.
    LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1854 - 1859
  • [25] Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL).
    Kusumi, E
    Tanimoto, TE
    Kami, M
    Hamaki, T
    Yuji, K
    Ueyama, J
    Miyakoshi, S
    Morinaga, S
    Kanda, Y
    Makimoto, A
    Kataoka, I
    Kim, SW
    Ohnishi, M
    Nakai, K
    Tobinai, K
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    Mutou, Y
    BLOOD, 2001, 98 (11) : 377B - 377B
  • [26] The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma
    Osmanilhan
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    BLOOD, 2021, 138
  • [27] Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma
    Morris, EC
    Mackinnon, S
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (01) : 129 - 142
  • [28] Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients
    Fenske, Timothy S.
    Hamadani, Mehdi
    Cohen, Jonathon B.
    Costa, Luciano J.
    Kahl, Brad S.
    Evens, Andrew M.
    Hamlin, Paul A.
    Lazarus, Hillard M.
    Petersdorf, Effie
    Bredeson, Christopher
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1543 - 1551
  • [29] Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
    Smith, Sonali M.
    Burns, Linda J.
    van Besien, Koen
    LeRademacher, Jennifer
    He, Wensheng
    Fenske, Timothy S.
    Suzuki, Ritsuro
    Hsu, Jack W.
    Schouten, Harry C.
    Hale, Gregory A.
    Holmberg, Leona A.
    Sureda, Anna
    Freytes, Cesar O.
    Maziarz, Richard Thomas
    Inwards, David J.
    Gale, Robert Peter
    Gross, Thomas G.
    Cairo, Mitchell S.
    Costa, Luciano J.
    Lazarus, Hillard M.
    Wiernik, Peter H.
    Maharaj, Dipnarine
    Laport, Ginna G.
    Montoto, Silvia
    Hari, Parameswaran N.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3100 - +
  • [30] Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
    Kimimori Kamijo
    Yoshimitsu Shimomura
    Akihito Shinohara
    Shohei Mizuno
    Minoru Kanaya
    Yoshiaki Usui
    Sung-Won Kim
    Takahide Ara
    Ishikazu Mizuno
    Takuro Kuriyama
    Hideyuki Nakazawa
    Ken-ichi Matsuoka
    Shigeru Kusumoto
    Nobuo Maseki
    Masaki Yamaguchi
    Takashi Ashida
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Eisei Kondo
    Annals of Hematology, 2023, 102 : 651 - 661
12345